Objective-Behçet's disease (BD) is a rare, multisystem inflammatory disorder of unknown cause. Although well-documented in Eastern populations, epidemiologic data is scarce in North American countries. Here we describe the incidence and prevalence of BD in Olmsted County, Minnesota over 45 years.
INTRODUCTION
Behçet's disease (BD) is a rare, multisystem inflammatory disorder of unknown cause. Historically, BD traces the Old Silk Road, the ancient trade route following the eastern shores of the Mediterranean Sea, corresponding to the 30th and 45th degree Northern latitudes (1, 2) . Onset of BD usually occurs in the third decade of life with an equal sex predilection in most patient series, although a male preponderance in the Turkish population has been described (1, 3, 4) . Regional differences in clinical characteristics may exist between Eastern and Western populations. In the West, ocular lesions are less common, with less familial occurrence and pathergy (3, (5) (6) (7) (8) (9) . However, a recent systematic review by Lewis et al has refuted ethnic variation in BD phenotype (10) .
Although BD is well-documented in the Middle Eastern and Japanese populations with an incidence of 0.58 per 100,000 population and a prevalence in Turkey as high as 420 per 100,000 population, epidemiologic data is scarce in the Western hemisphere, especially in North America (1, 3, (11) (12) (13) (14) . Recent data indicate an incidence estimate of 0.24 per 100,000 population in northern Italy, but prevalence estimates vary widely in Europe and the US, between 0.12 and 7.5 per 100,000 population (1, 3, 13, 15, 16) . Time trend studies suggest an increase in prevalence over the decades, which may be due to increased disease recognition (17) and migration in some countries (3, 18) . For example, the prevalence in Japan increased from 6.3 to 8.5 per 100,000 population in the 1970s to 13.5 per 100,000 population in 1991, with similar trends observed in Germany and Italy (1, (18) (19) (20) .
In North America, O'Duffy and colleagues in the 1970s and early 1980s in Olmsted County, Minnesota estimated the point prevalence of BD at 0.3 per 100,000 population (ref. 21 and O'Duffy et al: unpublished observations). Later prevalence estimates in the same population were as high as 5 to 6.6 per 100,000 population (22, 23) . In this study, we aimed to confirm the earlier estimates by determining time trends in the incidence, prevalence, and clinical characteristics of BD over a 45-year period in Olmsted County, Minnesota.
SUBJECTS AND METHODS

Study setting
We conducted a retrospective, population-based study in Olmsted County, Minnesota, a relatively isolated, homogenous community where health care to the local population is provided by a limited number of providers. Population-based research in this community is facilitated by the Rochester Epidemiology Project (REP), a comprehensive diagnostic indexing and medical records linkage system (24) . All medical, surgical, and histologic diagnoses and other key information from all health care providers are abstracted and entered into computerized indices to facilitate case identification. The REP ensures virtually complete ascertainment and followup of all clinically diagnosed cases of BD in this geographically defined community. Furthermore, the medical records are easily retrievable and available for review in both paper and electronic form.
Case definition and data collection
We reviewed the medical records of all subjects age ≥18 years who had International Classification of Diseases, Ninth Revision (ICD-9) diagnostic codes consistent with BD between January 1, 1960 and January 1, 2005 (ICD-9 codes 136.1 and 711.2). We also reviewed the medical records of a representative sample of subjects with at least 2 typical BD symptoms (e.g., aphthosis and uveitis and/or genital ulcer and/or uveitis). BD diagnosis was confirmed by a rheumatologist (KTC) and/or if subjects satisfied the International Study Group (ISG) criteria for BD (25) ( Table 1 ).
All demographic, clinical, and laboratory data were collected and entered into a standardized data abstraction form. Clinical characteristics included the presence of oral ulcers, genital ulcers, erythema nodosum, pseudofolliculitis, papulopustular lesions, acneiform nodules, anterior uveitis, posterior uveitis, panuveitis, retinal vasculitis, stroke, aseptic meningitis, superficial venous thrombosis, deep venous thrombosis, cerebral thrombosis, aortic aneurysms, pulmonary aneurysms, arthralgias, arthritis, gastrointestinal involvement, history of a positive pathergy test, and presence of HLA-B51.
Statistical analysis
Age-and sex-specific incidence estimates were estimated assuming individuals age ≥18 were at risk for BD. Age-and sex-specific incidence rates were estimated using the number of incident cases as the numerator and population estimates based on decennial census data as the denominator, with linear interpolation between census years (26) . Residents of Olmsted County at the onset of disease who were clinically diagnosed or fulfilled the ISG criteria for BD were included in the incidence cohort. Overall incidence rates were age-and sex-adjusted to the US 2000 total population. We constructed 95% confidence intervals (95% CIs) for the incidence rates using the assumption that the number of incident cases per year followed a Poisson distribution. Similarly, point prevalence was estimated on January 1, 2000.
RESULTS
We identified 83 subjects with diagnostic codes consistent with BD between January 1, 1960 and January 1, 2005. Of these subjects, 13 fulfilled criteria for inclusion in the incidence cohort. Eleven of these subjects fulfilled ISG criteria. Reasons for exclusion of the remaining subjects were as follows: did not fulfill BD criteria, prevalent BD subjects with disease onset outside of Olmsted County, subjects who were not residents of Olmsted County, and refusal of research authorization. Table 2 shows the clinical manifestations and complications of BD in 13 subjects. There were 9 women and 4 men, with a female to male ratio of 2.25:1. Mean ± SD age at incidence was 31 ± 9 years. The racial distribution was 69% white and 31% Asian. Oral ulcers were present in all of the subjects. Ocular complications were present in 8 subjects (62%), 7 of whom had anterior uveitis, 7 had posterior uveitis (6 had panuveitis), 5 had retinal vasculitis, and 1 had optic neuritis. Additionally, 1 subject had retinal detachment and another subject had chorioretinitis. Of the 8 subjects with ocular complications, 7 had ≥2 lesions. Genital ulcers were present in 8 (62%) of the 13 subjects. Dermatologic lesions included erythema nodosum in 6 subjects and papulopustular lesions in 7 subjects. Both erythema nodosum and papulopustular lesions were present in 2 subjects. Six of the 13 subjects had arthralgias and/or arthritis, including 1 with unilateral sacroiliitis. Central nervous system (CNS) complications included stroke (n = 2), aseptic meningitis (n = 1), and migraine headaches (n = 2), and 2 subjects had ≥2 complications. One subject had a stroke after the diagnosis of BD. Vascular complications were present in 3 subjects and included deep venous thrombosis (n = 2) and a superficial blood clot (n = 1). One subject with a deep venous thrombosis had the prothrombin 21210A gene mutation. None of the subjects were tested for the presence of the HLA-B51 gene or had a pathergy test performed. Table 3 shows the overall age-and sex-specific incidence of BD per decade of life. The overall age-and sex-adjusted incidence was 0.38 per 100,000 population (95% CI 0.17-0.59). The overall age-adjusted incidence was higher in women (0.51 per 100,000; 95% CI 0.17-0.84) than in men (0.26 per 100,000; 95% CI 0.004-0.52). Incidence was highest in the fifth decade of life in men (0.59 per 100,000) and in the third decade of life in women (1.14 per 100,000).
Demographic and clinical characteristics
Incidence and prevalence of BD
The overall age-and sex-adjusted point prevalence for BD on January 1, 2000 was 5.2 per 100,000 population (95% CI 0.64-9.84), based on 5 prevalence cases (4 of which were also incident). The sex-specific prevalence per 100,000 was 4.2 for men (95% CI 0.0-9.9) and 6.4 for women (95% CI 0.0-13.6).
DISCUSSION
To our knowledge, no previous study has systematically examined the epidemiology of BD in a stable, North American, population-based setting. In this study, we report the incidence and prevalence of BD in a geographically defined US population over a 45-year period. Our overall incidence estimate of 0.38 per 100,000 population agrees with previous incidence rates from other countries in the Western Hemisphere, thus confirming the previous observations that the incidence of BD is lower in Western populations. Similarly, our point prevalence estimate of 5.2 per 100,000 population is similar to previous estimates from other Western populations, but lower than rates seen in the Mediterranean and Japanese populations, suggesting a role for environmental and/or genetic factors in the pathogenesis of BD.
A higher incidence of BD among women in our study challenges the belief that BD occurs equally in both sexes. A similar sex pattern was observed in Asian studies (1, 27) . Reasons may be due to unknown environmental or genetic factors specific to our population, a change in the clinical manifestations of the disease, or the relatively higher proportion of Asians seen in our cohort than in other Western studies. During the study time period of 45 years, the proportion of Asians in Olmsted County increased from 0.2% to 5.1%, possibly due to increased economic opportunities, which may in part have accounted for the high proportion of Asians in our study.
Ocular complications in our BD cohort were more common than previously observed in other Western populations (3, 27) . In general, ocular lesions are reported to occur in approximately 48-75% of subjects with BD (3, 4, 6, 19, 28) . Our finding of 62% approaches the higher proportion of ocular complications seen in Asian populations (6, 27, 29) . This finding may be due to the higher proportion of Asians in our cohort; however, the possibility of surveillance bias at our center cannot be discounted. Also, patients with severe disease may have been followed more closely (6) . Finally, there may be a true change in the manifestations of BD over the 4 decades.
We also observed a higher percentage of CNS complications in our population than in other Western centers (1, 4) . CNS complications in BD usually manifest as aseptic meningitis or cerebral infarctions due to vasculitis, and they occur in approximately 11-48% of patients (5, 23, 30, 31) . Our finding of 23% agrees more with the rates commonly seen in the Mediterranean populations (1, 29) . The pattern of CNS involvement in our patients appeared to differ from the brain stem syndrome characterized by cranial nerve, cerebellar, or pyramidal signs as documented by Al-Araji and colleagues in Iraq, in that we observed more patients with strokes or migraine headaches (31) . A potential reason for our higher proportion of CNS manifestations may be due to underreporting of BD complications in nonendemic areas, given the relative rarity of BD (32) .
A potential concern in our study is overascertainment of BD cases. Although less typical forms of BD are harder to recognize in nonendemic areas (32) , the Mayo Clinic is a referral center for BD and most Mayo rheumatologists are aware of the signs and symptoms of the disease. Therefore, the incidence of clinically recognized BD in our community may be higher than other areas in the US. Additionally, although increased physician recognition over time may have influenced our incidence estimates, we were unable to examine this bias due to the small number of BD cases in our study. Considering the possibility that some BD cases may not have been clinically diagnosed, we identified and screened the medical records of a representative sample of subjects who had a constellation of diagnoses (at least 2 diagnoses) suggestive of BD. We reviewed the medical records of 40 subjects who had at least aphthosis, iritis or uveitis, and genital ulcers, and we found no cases of BD among them. In addition, over the course of 40 years, we anticipated that most BD cases would have been clinically recognized due to the comprehensive nature of our medical records linkage system provided by the REP (24) .
Our study has several other potential limitations common to most retrospective studies. First, there is the possibility of reviewer/detection bias. However, the majority of data abstraction in this study was performed by one author (KTC) using a standardized data abstraction form that included explicit variable definitions provided by the ISG criteria (25). Second, the information in the medical records may be subject to clinician variability; it is possible that clinical variables may have been incompletely documented. Finally, the characteristics of our homogenous population limit the generalization of our findings to more racially and economically diverse populations.
Nevertheless, strengths of our study include the unique ability to examine the incidence and prevalence of BD in a stable North American population. In addition, the unique medical records linkage system provided by the REP allows for virtually complete ascertainment of all clinically recognized BD cases.
In conclusion, our findings indicate that the incidence and prevalence of BD in North America is comparable to other Western populations. In addition, we report a higher proportion of women with BD than is seen in Western populations. Finally, our study shows that ocular and CNS involvement may be more prevalent in Western populations than previously estimated. Further research is needed to elucidate the sex-specific patterns of BD, the reasons for BD prevalence in women in our population, as well as the increased proportion of ocular and CNS complications. 
